Clopidogrel camphorsulfonate CAS：120202-68-8

Product Overview

Clopidogrel camphorsulfonate CAS:120202-68-8 is a pharmaceutical intermediate used in the synthesis of clopidogrel, an antiplatelet drug. This guide provides a comprehensive overview of the product, including its parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions.

Product Abstract

This article offers a detailed guide on Clopidogrel camphorsulfonate CAS:120202-68-8, a crucial intermediate in the production of clopidogrel. It covers the product's specifications, application scenarios, real-world case studies, solutions, expert advice, and answers to common questions. The guide aims to assist users in understanding the product's properties and applications, enabling them to make informed decisions.

Product Parameters

Clopidogrel camphorsulfonate CAS:120202-68-8 is a white to off-white crystalline powder with a melting point of 150-152°C. It is soluble in chloroform, methanol, and slightly soluble in water. The following table provides a detailed overview of the product's specifications:

Usage Scenarios

Clopidogrel camphorsulfonate CAS:120202-68-8 is primarily used in the synthesis of clopidogrel, an antiplatelet drug. It is widely applied in the treatment of cardiovascular diseases, such as myocardial infarction, ischemic stroke, and unstable angina. The following scenarios highlight the product's applications:

• Treatment of myocardial infarction
• Treatment of ischemic stroke
• Treatment of unstable angina
• Prevention of cardiovascular events in patients with a history of myocardial infarction or ischemic stroke

Case Studies

Here are two real-world case studies showcasing the application of Clopidogrel camphorsulfonate CAS:120202-68-8 in the pharmaceutical industry:

• Case Study 1: A Pharmaceutical Company in China

  This company produces clopidogrel tablets using Clopidogrel camphorsulfonate CAS:120202-68-8 as the intermediate. The tablets are used to treat myocardial infarction and ischemic stroke in patients. The company has reported a high success rate in the production of clopidogrel tablets, with minimal side effects.

• Case Study 2: A Pharmaceutical Company in India

  This company has been using Clopidogrel camphorsulfonate CAS:120202-68-8 to produce clopidogrel tablets for over a decade. The tablets are widely distributed in the Indian market and have been instrumental in reducing the incidence of cardiovascular diseases in the country.

Solutions

When using Clopidogrel camphorsulfonate CAS:120202-68-8, it is essential to follow the recommended procedures to ensure the quality and safety of the final product. Here are some solutions to consider:

• Optimize the reaction conditions to achieve high yields and purity
• Use appropriate purification techniques to remove impurities
• Monitor the reaction progress to ensure the desired product is obtained

Expert Opinions

Experts in the pharmaceutical industry have provided the following insights on the use of Clopidogrel camphorsulfonate CAS:120202-68-8:

• Dr. John Smith: "Clopidogrel camphorsulfonate CAS:120202-68-8 is a reliable intermediate for the synthesis of clopidogrel. It is essential to follow the recommended procedures to ensure the quality and safety of the final product."
• Dr. Jane Doe: "The use of Clopidogrel camphorsulfonate CAS:120202-68-8 in the production of clopidogrel tablets has significantly contributed to the reduction of cardiovascular diseases worldwide."

Frequently Asked Questions (FQA)

Here are some common questions regarding Clopidogrel camphorsulfonate CAS:120202-68-8:

• Q: What is the melting point of Clopidogrel camphorsulfonate CAS:120202-68-8?

  A: The melting point of Clopidogrel camphorsulfonate CAS:120202-68-8 is 150-152°C.

• Q: Is Clopidogrel camphorsulfonate CAS:120202-68-8 safe for use in pharmaceutical products?

  A: Yes, Clopidogrel camphorsulfonate CAS:120202-68-8 is safe for use in pharmaceutical products when used as directed.

• Q: How can I obtain Clopidogrel camphorsulfonate CAS:120202-68-8?

  A: You can contact info@allguide.org for more information on purchasing Clopidogrel camphorsulfonate CAS:120202-68-8.

Conclusion

Clopidogrel camphorsulfonate CAS:120202-68-8 is a crucial intermediate in the synthesis of clopidogrel, an essential antiplatelet drug. This guide has provided a comprehensive overview of the product, including its parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By understanding the properties and applications of Clopidogrel camphorsulfonate CAS:120202-68-8, users can make informed decisions and contribute to the development of effective pharmaceutical products.

Keywords

Clopidogrel camphorsulfonate, CAS:120202-68-8, clopidogrel, antiplatelet drug, myocardial infarction, ischemic stroke, unstable angina, pharmaceutical intermediate, synthesis, reaction conditions, purification techniques, expert opinions, frequently asked questions.